1. Nonclinical and quality assessment of cell therapy products: Report on the 4th Asia Partnership Conference of Regenerative Medicine, April 15, 2021.
- Author
-
Yoneda, Tomohiro, Tanaka, Toshimitsu, Bando, Kiyoko, Choi, Byung Hyune, Chang, Ryan, Fujiwara, Yukari, Gupta, Pawan Kumar, Ham, Dong-sik, Karasawa, Hiroshi, Kuwae, Shinobu, Lee, Shing-mou, Moriya, Yuu, Takakura, Koji, Tsurumaki, Yoshie, Watanabe, Takeshi, Yoshimura, Keiji, and Nomura, Masayuki
- Subjects
- *
REGENERATIVE medicine , *CELLULAR therapy , *GOVERNMENT agencies , *CONFERENCES & conventions - Abstract
The 4th Asia Partnership Conference of Regenerative Medicine (APACRM) was held online on April 15, 2021, to promote regulatory harmonization of regenerative medicine products throughout Asia. Recognizing domestic regulatory guidelines within each country and region, and their underpinning rationales, is an important initial step toward a convergence of regulations. The 4th APACRM consisted of an open dialog with regulatory agencies regarding nonclinical and quality settings for cell therapy products (CTPs) through industry presentations and panel discussions with regulatory agencies. The latest updates on regenerative medicine fields in each country and region, and specific regulatory schematics in Japan, were also introduced. The objective of this paper is to summarize the proceedings of the 4th APACRM for public dissemination and to foster further discussion in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF